New-onset atrial fibrillation in severe sepsis and risk of stroke and death: A critically appraised topic

Neurologist

Volumn 18, Issue 4, 2012, Pages 239-243

  Lee Iannotti, Joyce K ^a   Capampangan, Dan J ^a   Hoffman Snyder, Charlene ^a   Wellik, Kay E ^b   Patel, Bhavesh ^c   Tondato, Fernando ^a   Wingerchuk, Dean M ^a   Demaerschalk, Bart M ^a  

^a MAYO CLINIC   (United States)

^b Division of Education Administration   (United States)

^c Critical Care Medicine   (United States)

Author keywords

atrial fibrillation; cerebrovascular disease; critically appraised topic; death; evidence based medicine; new onset atrial fibrillation; sepsis; stroke

Indexed keywords

ABDOMINAL INFECTION; ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CARDIOVERSION; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LUNG INFECTION; PRIORITY JOURNAL; RACE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SEX DIFFERENCE; STROKE;

AGED, 80 AND OVER; ATRIAL FIBRILLATION; HUMANS; MALE; PROGNOSIS; RISK FACTORS; SEPSIS; STROKE;

EID: 84863596157     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31825fa850     Document Type: Article

References (27)

1. Artucio H, Pereira M. Cardiac arrhythmias in critically ill patients: Epidemiologic study. Crit Care Med. 1990;18:1383-1388.
2. Annane D, Sebille V, Duboc D, et al. Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med. 2008;178:20-25. (Pubitemid 351919189)
3. Goodman S, Shirov T, Weissman C. Supraventricular arrhythmias in intensive care units patients: Short and long-term consequences. Anesth Analg. 2007;104:880-886. (Pubitemid 46548315)
4. Arora S, Lang I, Nayyar V, et al. Atrial fibrillation in a tertiary care multidisciplinary intensive care unit-incidence and risk factors. Anaesth Intensive Care. 2007;35:707-713. (Pubitemid 47572094)
5. Meierhenrich R, Steinhilber E, Eggermann C, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock; a prospective observational study. Crit Care. 2010;14:1-8.
6. Christian SA, Schorr C, Ferchau L, et al. Clinical characteristics and outcomes of septic patients with new-onset atrial fibrillation. J Crit Care. 2008;23:532-536.
7. Salman S, Bajwa A, Gajic O, et al. Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med. 2008;23: 178-183. (Pubitemid 351698671)
8. Walkey AJ, Wiener RS, Ghobrial J, et al. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306:2248-2255.
9. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310. (Pubitemid 32641789)
10. Hansson A, Madsen-Hardig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: A study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovasc Disord. 2004;4:1-9.
11. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010. (Pubitemid 37553570)
12. Nakada TA, Russell JA, Boyd JH, et al. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med. 2010;181:143-149.
13. Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010;33:375-380.
14. Levy B, Dusang B, Annane D, et al. Cardiovascular response to dopamine and early prediction of outcome in septic shock: A prospective multiple-center study. Crit Care Med. 2005;33: 2172-2177. (Pubitemid 41437467)
15. Howell MD, Talmor D, Schuetz P, et al. Proof of principle: The predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39:322-327.
16. Rivers EP, Coba V, Whitmill M. Early goal-directed therapy in severe sepsis and septic shock: A contemporary review of the literature. Curr Opin Anaesthesiol. 2008;21:128-140.
17. Burkhart CS, Siegemund M, Steiner LA. Cerebral perfusion in sepsis. Crit Care. 2010;14:1-5.
18. Iba T, Kidokoro A. What can we learn from the three megatrials using anticoagulants in severe sepsis? Shock. 2004;22:508-512. (Pubitemid 39576577)
19. Ely EW, Laterre PF, Angus DC, et al. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med. 2003;31:12-19. (Pubitemid 36151143)
20. Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veteran Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
21. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285: 2370-2375. (Pubitemid 32424106)
22. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:5465-5925.
23. Gage BF, Waterman AD, Shanon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA. 2001;285: 2864-2870. (Pubitemid 32537350)
24. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest. 2010;137:263-272.
25. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003;41:1633-1652. (Pubitemid 36543387)
26. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010;138:1093-1100.
27. Goss CH, Carson SS. Is severe sepsis associated with new-onset atrial fibrillation and stroke? JAMA. 2011;306:2264-2266.